Bayer AG (all manufacturing stages)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of adults with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH) to increase exercise tolerance.
Dosage form: tablets, film-coated
Active substance Dosage riociguat 2.5 mg ATC: C02KX05
-
The drug is used for the treatment of adults with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH) to increase exercise tolerance.
Dosage form: tablets, film-coated
Active substance Dosage riociguat 1.5 mg ATC: C02KX05
-
The drug is used for the treatment of adults with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH) to increase exercise tolerance.
Dosage form: tablets, film-coated
Active substance Dosage riociguat 0.5 mg ATC: C02KX05
-
The drug is used for the treatment of adults with chronic thromboembolic pulmonary hypertension (inoperable or recurrent after surgical intervention), as well as for the treatment of pulmonary arterial hypertension (either as monotherapy or in combination with certain other agents).
Dosage form: tablets, film-coated
Active substance Dosage riociguat 2 mg ATC: C02KX05
-
The drug is used for the treatment of adults with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH) to increase exercise tolerance.
Dosage form: tablets, film-coated
Active substance Dosage riociguat 1 mg ATC: C02KX05